Abstract
Hirschsprung’s disease (HSCR) is a common cause of neonatal bowel obstruction and the approach to diagnosis and surgical treatment is well defined and accepted. Hirschsprung’s-associated enterocolitis (HAEC) remains a frequent cause of pre-operative and post-operative morbidity and mortality, with unchanged treatment guidelines over multiple decades. Recent advances in our understanding of the genetics underlying HSCR have allowed the development of animal models, some of which recapitulate the HAEC phenotype. These animal models, along with recent translational studies, have implicated multiple facets of mucosal immunity and microbiome dysbiosis in the development of HAEC. Here, we will review the established epidemiology, modes of diagnosis and treatment of HAEC. Furthermore, we will explore emerging concepts in the pathogenesis of this disease; including animal models, alterations in mucosal immunity, dysbiosis of the intestinal microbiome, specific genetic susceptibility, and novel treatment modalities.
Similar content being viewed by others
References
Hirschspring H (1888) Constipation in newborns due to dilation and hypertrophy of the colon. Jahrbuch Kinderheikunde
Raffensperger JG (1987) Hirschsprung’s disease: a historical review. Bull Soc Sci Med Grand Duche Luxemb 124:31–36
Engum SA, Grosfeld JL (2004) Long-term results of treatment of Hirschsprung’s disease. Semin Pediatr Surg 13:273–285. doi:10.1053/j.sempedsurg.2004.10.015
Kenny SE, Tam PKH, Garcia-Barcelo M (2010) Hirschsprung’s disease. Semin Pediatr Surg 19:194–200. doi:10.1053/j.sempedsurg.2010.03.004
Baxter KJ, Bhatia AM (2013) Hirschsprung’s disease in the preterm infant: implications for diagnosis and outcome. Am Surg 79:734–738
Duess JW, Hofmann AD, Puri P (2014) Prevalence of Hirschsprung’s disease in premature infants: a systematic review. Pediatr Surg Int 30:791–795. doi:10.1007/s00383-014-3540-8
Downey EC, Hughes E, Putnam AR et al (2015) Hirschsprung disease in the premature newborn: a population based study and 40-year single center experience. J Pediatr Surg 50:123–125. doi:10.1016/j.jpedsurg.2014.10.013
Austin KM (2012) The pathogenesis of Hirschsprung’s disease-associated enterocolitis. YSPSU 21:319–327. doi:10.1053/j.sempedsurg.2012.07.006
Frykman PK, Short SS (2012) Hirschsprung-associated enterocolitis: prevention and therapy. YSPSU 21:328–335. doi:10.1053/j.sempedsurg.2012.07.007
Foster P, Cowan G, Wrenn EL (1990) Twenty-five years“experience with Hirschsprung”s disease. J Pediatr Surg 25:531–534
Rescorla FJ, Morrison AM, Engles D et al (1992) Hirschsprung’s disease. Evaluation of mortality and long-term function in 260 cases. Arch Surg 127:934–41 (discussion 941–2)
Harrison MW, Deitz DM, Campbell JR, Campbell TJ (1986) Diagnosis and management of Hirschsprung’s disease. A 25 year perspective. AJS 152:49–56
Pini-Prato A, Rossi V, Avanzini S et al (2011) Hirschsprung’s disease: what about mortality? Pediatr Surg Int 27:473–478. doi:10.1007/s00383-010-2848-2
Dalkey N, Helmer O (1963) An experimental application of the Delphi method to the use of experts. Manag Sci 9:458–467
Pastor AC, Osman F, Teitelbaum DH et al (2009) Development of a standardized definition forHirschsprung’s-associated enterocolitis:a Delphi analysis. J Pediatr Surg 44:251–256. doi:10.1016/j.jpedsurg.2008.10.052
Brearly S, Armstrong GR, Nairn R et al (1987) Pseudomembranous colitis: a lethal complication of Hirschsprung’s disease unrelated to antibiotic usage. J Pediatr Surg 22:257–259
Marty TL, Seo T, Matlak ME et al (1995) Gastrointestinal function after surgical correction of Hirschsprung’s disease: long-term follow-up in 135 patients. J Pediatr Surg 30:655–658
Fujimoto T (1988) Natural history and pathophysiology of enterocolitis in the piebald lethal mouse model of Hirschsprung’s disease. J Pediatr Surg 23:237–242
Demehri FR, Halaweish IF, Coran AG, Teitelbaum DH (2013) Hirschsprung-associated enterocolitis: pathogenesis, treatment and prevention. Pediatr Surg Int 29:873–881. doi:10.1007/s00383-013-3353-1
Lyonnet S, Bolino A, Pelet A et al (1993) A gene for Hirschsprung disease maps to the proximal long arm of chromosome 10. Nat Genet 4:346–350. doi:10.1038/ng0893-346
Romeo G, Ronchetto P, Luo Y et al (1994) Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung’s disease. Nature 367:377–378. doi:10.1038/367377a0
Amiel J, Sproat-Emison E, Garcia-Barcelo M et al (2008) Hirschsprung disease, associated syndromes and genetics: a review. J Med Genet 45:1–14. doi:10.1136/jmg.2007.053959
Veiga-Fernandes H, Coles MC, Foster KE et al (2007) Tyrosine kinase receptor RET is a key regulator of Peyer’s Patch organogenesis. Nature 446:547–551. doi:10.1038/nature05597
Schuchardt A, D’Agati V, Larsson-Blomberg L et al (1994) Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret. Nature 367:380–383. doi:10.1038/367380a0
Nagy N, Goldstein AM (2006) Endothelin-3 regulates neural crest cell proliferation and differentiation in the hindgut enteric nervous system. Dev Biol 293:203–217. doi:10.1016/j.ydbio.2006.01.032
Gariepy CE, Cass DT, Yanagisawa M (1996) Null mutation of endothelin receptor type B gene in spotting lethal rats causes aganglionic megacolon and white coat color. Proc Natl Acad Sci USA 93:867–872
Druckenbrod NR, Powers PA, Bartley CR et al (2008) Targeting of endothelin receptor-B to the neural crest. Genesis 46:396–400. doi:10.1002/dvg.20415
Cheng Z, Dhall D, Zhao L et al (2010) Murine model of Hirschsprung-associated enterocolitis.I: phenotypic characterization with development of ahistopathologic grading system. J Pediatr Surg 45:475–482. doi:10.1016/j.jpedsurg.2009.06.009
Zhao L, Dhall D, Cheng Z et al (2010) Murine model of Hirschsprung-associated enterocolitis II: surgical correction of aganglionosis does noteliminate enterocolitis. J Pediatr Surg 45:206–212. doi:10.1016/j.jpedsurg.2009.10.035
Cheng Z, Wang X, Dhall D et al (2010) Splenic lymphopenia in the endothelin receptor B-null mouse: implications for Hirschsprung associated enterocolitis. Pediatr Surg Int 27:145–150. doi:10.1007/s00383-010-2787-y
Ward NL, Pieretti A, Dowd SE et al (2012) Intestinal aganglionosis is associated with early and sustained disruption of the colonic microbiome. Neurogastroenterol Motil 24:e400–e874. doi:10.1111/j.1365-2982.2012.01937.x
Thiagarajah JR, Yildiz H, Carlson T et al (2014) Altered goblet cell differentiation and surface mucus properties in Hirschsprung disease. PLoS One 9:e99944. doi:10.1371/journal.pone.0099944.t001
Frykman PK, Cheng Z, Wang X, Dhall D (2015) Enterocolitis causes profound lymphoid depletion in endothelin receptor B- and endothelin 3-null mouse models of Hirschsprung-associated enterocolitis. Eur J Immunol 45:807–817. doi:10.1002/eji.201444737
Yildiz HM, Carlson TL, Goldstein AM, Carrier RL (2015) Mucus barriers to microparticles and microbes are altered in Hirschsprung’s disease. Macromol Biosci 15:712–718. doi:10.1002/mabi.201400473
Pierre JF, Barlow-Anacker AJ, Erickson CS et al (2014) Intestinal dysbiosis and bacterial enteroinvasion in a murine model of Hirschsprung’s disease. J Pediatr Surg 49:1242–1251. doi:10.1016/j.jpedsurg.2014.01.060
Gosain A, Barlow-Anacker AJ, Erickson CS et al (2015) Impaired cellular immunity in the murine neural crest conditional deletion of endothelin receptor-B model of Hirschsprung’s disease. PLoS One 10:e0128822. doi:10.1371/journal.pone.0128822
Brandtzaeg P, Kiyono H, Pabst R, Russell MW (2008) Terminology: nomenclature of mucosa-associated lymphoid tissue. Mucosal Immunol 1:31–37. doi:10.1038/mi.2007.9
Craig SW, Cebra JJ (1971) Peyer’s patches: an enriched source of precursors for IgA-producing immunocytes in the rabbit. J Exp Med 134:188–200
Berlin C, Berg EL, Briskin MJ et al (1993) Alpha 4 beta 7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1. Cell 74:185–195
Berg EL, McEvoy LM, Berlin C et al (1993) L-selectin-mediated lymphocyte rolling on MAdCAM-1. Nature 366:695–698. doi:10.1038/366695a0
Bowman EP, Kuklin NA, Youngman KR et al (2002) The intestinal chemokine thymus-expressed chemokine (CCL25) attracts IgA antibody-secreting cells. J Exp Med 195:269–275
Uren TK, Johansen F-E, Wijburg OLC et al (2003) Role of the polymeric Ig receptor in mucosal B cell homeostasis. J Immunol 170:2531–2539
Imamura A, Puri P, O’Briain DS, Reen DJ (1992) Mucosal immune defence mechanisms in enterocolitis complicating Hirschsprung’s disease. Gut 33:801–806. doi:10.1136/gut.33.6.801
Gosain A, Barlow-Anacker AJ, Erickson CS et al (2015) Impaired cellular immunity in the murine neural crest conditional deletion of endothelin receptor-B model of Hirschsprung’s disease. PLoS One 10:e0128822. doi:10.1371/journal.pone.0128822.s001
Rosado MM, Aranburu A, Capolunghi F et al (2009) From the fetal liver to spleen and gut: the highway to natural antibody. Mucosal Immunol 2:351–361. doi:10.1038/mi.2009.15
Zhao L, Cheng Z, Dhall D et al (2009) A novel corrective pullthrough surgery in a mouse model of Hirschsprung’s disease. J Pediatr Surg 44:759–766. doi:10.1016/j.jpedsurg.2008.06.006
Keita ÅV, Söderholm JD (2010) The intestinal barrier and its regulation by neuroimmune factors. Neurogastroenterol Motil 22:718–733. doi:10.1111/j.1365-2982.2010.01498.x
Teitelbaum DH, Caniano DA, Qualman SJ (1989) The pathophysiology of Hirschsprung’s-associated enterocolitis: importance of histologic correlates. J Pediatr Surg 24:1271–1277
Aslam A, Spicer RD, Corfield AP (1997) Biochemical analysis of colonic mucin glycoproteins in children with Hirschsprung disease show disease specific alterations. Biochem Soc Trans 25:8S
Mattar AF, Coran AG, Teitelbaum DH (2003) MUC-2 mucin production in Hirschsprung’s disease: possible association with enterocolitis development. J Pediatr Surg 38:417–421. doi:10.1053/jpsu.2003.50071
Karlsson J, Pütsep K, Chu H et al (2008) Regional variations in Paneth cell antimicrobial peptide expression along the mouse intestinal tract. BMC Immunol 9:37. doi:10.1186/1471-2172-9-37
Alverdy J, Gilbert J, DeFazio JR et al (2014) Proceedings of the 2013 A.S.P.E.N. Research workshop: the interface between nutrition and the gut microbiome: implications and applications for human health [corrected]. JPEN J Parenter Enteral Nutr 38:167–178. doi:10.1177/0148607113517904
De Filippo C, Pini-Prato A, Mattioli G et al (2010) Genomics approach to the analysis of bacterial communities dynamics in Hirschsprung’s disease-associated enterocolitis: a pilot study. Pediatr Surg Int 26:465–471. doi:10.1007/s00383-010-2586-5
Yan Z, Poroyko V, Gu S et al (2014) Biochemical and biophysical research communications. Biochem Biophys Research Commun 445:269–274. doi:10.1016/j.bbrc.2014.01.104
Frykman PK, Nordenskjöld A, Kawaguchi A et al (2015) Characterization of bacterial and fungal microbiome in children with Hirschsprung disease with and without a history of enterocolitis: a multicenter study. PLoS One 10:e0124172. doi:10.1371/journal.pone.0124172
Hugot JP, Chamaillard M, Zouali H et al (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature 411:599–603. doi:10.1038/35079107
Barreau F, Meinzer U, Chareyre F et al (2007) CARD15/NOD2 Is Required for Peyer’s Patches Homeostasis in Mice. PLoS ONE 2:e523. doi:10.1371/journal.pone.0000523.s004
Lacher M, Fitze G, Helmbrecht J et al (2010) Hirschsprung-associated enterocolitis develops independently of NOD2 variants. J Pediatr Surg 45:1826–1831. doi:10.1016/j.jpedsurg.2010.02.039
Moore SW, Sidler D, Zaahl MG (2008) The ITGB2 immunomodulatory gene (CD18), enterocolitis, and Hirschsprung’s disease. J Pediatr Surg 43:1439–1444. doi:10.1016/j.jpedsurg.2007.12.057
El-Sawaf M, Siddiqui S, Mahmoud M et al (2013) Probiotic prophylaxis after pullthrough for Hirschsprung disease to reduce incidence of enterocolitis: a prospective, randomized, double-blind, placebo-controlled, multicenter trial. J Pediatr Surg 48:111–117. doi:10.1016/j.jpedsurg.2012.10.028
Wang X, Li Z, Xu Z et al (2015) Probiotics prevent Hirschsprung’s disease-associated enterocolitis: a prospective multicenter randomized controlled trial. Int J Colorectal Dis 30:105–110. doi:10.1007/s00384-014-2054-0
Acknowledgments
This work was supported by the National Institutes of Health (K08DK098271) and the American College of Surgeons (George H.A. Clowes Award) to AG.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gosain, A. Established and emerging concepts in Hirschsprung’s-associated enterocolitis. Pediatr Surg Int 32, 313–320 (2016). https://doi.org/10.1007/s00383-016-3862-9
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00383-016-3862-9